Human leukocyte antigen class I on peripheral blood mononuclear cells as a non-invasive biomarker for esophageal cancer

Diseases of the Esophagus

Volumn 25, Issue 3, 2012, Pages 273-278

  Zhang, Z ^a   Li, Y ^a   Guan, X ^a   Yang, X ^a,a   Li, S ^a   Zou, X ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Esophageal neoplasm; FACS; HLA I; PBMC; Q PCR

Indexed keywords

HLA ANTIGEN CLASS 1; MESSENGER RNA;

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EARLY DIAGNOSIS; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; FEASIBILITY STUDY; FEMALE; FLOW CYTOMETRY; GENDER; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHINA; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOPLASM STAGING; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84859632867     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2011.01245.x     Document Type: Article

References (28)

1. Harbord M, Dawes R F, Barr H etal. Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel. Gastrointest Endosc 2002; 56: 644-51.
2. Matsuzaki I, Suzuki H, Kitamura M, Minamiya Y, Kawai H, Ogawa J. Cisplatin induces fas expression in esophageal cancer cell lines and enhanced cytotoxicity in combination with LAK cells. Oncology 2000; 59: 336-43.
3. Arnott S J, Duncan W, Gignoux M etal. Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998; 41: 579-83.
4. Kelsen D P, Ginsberg R, Pajak T F etal. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-84.
5. MRC. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359: 1727-33.
6. Lingfang S, Yuhang C, Zhongren G etal. Surgical treatment of carcinoma of esophagus and gastric cardia - a 34-year investigation. Chin Ger J Clin Oncol 2002; 1: 61-4.
7. Townsend A R, Rothbard J, Gotch F M, Bahadur G, Wraith D, McMichael A J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986; 44: 959-68.
8. Ljunggren H G, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237-44.
9. Rajendra S, Ackroyd R, Karim N, Mohan C, Ho J J, Kutty M K. Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus. J Clin Pathol 2006; 59: 952-7.
10. Nie Y, Yang G, Song Y etal. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 2001; 22: 1615-23.
11. Mizukami Y, Kono K, Maruyama T etal. Downregulation of HLA class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 2008; 99: 1462-7.
12. Hu S P, Zhou G B, Luan J A etal. Polymorphisms of HLA-A and HLA-B genes in genetic susceptibility to esophageal carcinoma in Chaoshan Han Chinese. Dis Esophagus 2009; 23: 46-52.
13. Zhang Y, Liu Y, Lu N etal. Expression of the genes encoding human leucocyte antigens-A, -B, -DP, -DQ and -G in gastric cancer patients. J Int Med Res 2010; 38: 949-56.
14. Brown L M, Hoover R, Silverman D etal. Excess incidence of squamous cell esophageal cancer among US black men: role of social class and other risk factors. Am J Epidemiol 2001; 153: 114-22.
15. Blot W J. Esophageal cancer trends and risk factors. Semin Oncol 1994; 21: 403-10.
16. Li W, Guo X L, Fu Z T etal. Case-control study on risk factors of esophageal cancer. Chin J Public Health 2008; 24: 517-18.
17. Wang C X, Wang J F, Liu M etal. Expression of HLA class I and II on peripheral blood lymphocytes in HBV infection. Chin Med J (Engl) 2006; 119: 753-6.
18. Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-8.
19. Plaksin D, Gelber C, Feldman M, Eisenbach L. Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene. Proc Natl Acad Sci USA 1988; 85: 4463-7.
20. Porgador A, Feldman M, Eisenbach L. H-2Kb transfection of B16 melanoma cells results in reduced tumourigenicity and metastatic competence. J Immunogenet 1989; 16: 291-303.
21. Whiteside T L, Stanson J, Shurin M R, Ferrone S. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells. J Immunol 2004; 173: 1526-34.
22. Petersson M, Charo J, Salazar-Onfray F etal. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J Immunol 1998; 161: 2099-105.
23. Zeidler R, Eissner G, Meissner P etal. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood 1997; 90: 2390-7.
24. Gholamin M, Moaven O, Memar B etal. Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma. World J Surg 2009; 33: 1439-45.
25. Orlikowsky T, Wang Z, Dudhane A etal. Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion. Immunology 1998; 95: 437-42.
26. d gene by antisense oligonucleotides complementary has effect on the cytotoxicity of LAK cells in mouse. Chin J Lab Med 2004; 27: 27-9.
27. Apasov S G, Sitkovsky M V. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells. J Immunol 1994; 152: 2087-97.
28. Liu Q, Hao C, Su P, Shi J. Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: association with disease progression. Scand J Gastroenterol 2009; 44: 960-9.